Literature DB >> 24346391

Oral paracetamol in treatment of closure of patent ductus arteriosus in preterm neonates.

B Jasani1, N Kabra, R N Nanavati.   

Abstract

We herewith report a case series of six premature neonates with hemodynamically significant paten ductus successfully treated with oral paracetamol. This is a first case series describing the use of oral paracetamol treatment patent ductus in preterm neonates from India. Further prospective randomized-controlled trials are needed to evaluate the efficacy and safety of oral paracetamol in the treatment of patent ductus in preterm neonates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24346391     DOI: 10.4103/0022-3859.123164

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  8 in total

1.  Acetaminophen to avoid surgical ligation in extremely low gestational age neonates with persistent hemodynamically significant patent ductus arteriosus.

Authors:  D E Weisz; F F Martins; L E Nield; A El-Khuffash; A Jain; P J McNamara
Journal:  J Perinatol       Date:  2016-04-07       Impact factor: 2.521

2.  Intravenous paracetamol for PDA closure in the preterm: a single-center experience.

Authors:  Enrico Valerio; Marta Rossella Valente; Sabrina Salvadori; Anna Chiara Frigo; Eugenio Baraldi; Paola Lago
Journal:  Eur J Pediatr       Date:  2016-05-05       Impact factor: 3.183

Review 3.  Different approaches for patent ductus arteriosus in premature infants using acetaminophen.

Authors:  Aimann Surak; Amish Jain; Abbas Hyderi
Journal:  World J Pediatr       Date:  2022-03-06       Impact factor: 2.764

4.  Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol.

Authors:  Ana García-Robles; Ana Gimeno Navarro; María Del Mar Serrano Martín; María José Párraga Quiles; Anna Parra Llorca; José Luis Poveda-Andrés; Máximo Vento Torres; Marta Aguar Carrascosa
Journal:  Front Pediatr       Date:  2020-07-17       Impact factor: 3.418

Review 5.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

6.  Efficacy of Paracetamol in Closure of Ductus Arteriosus in Infants under 32 Weeks of Gestation.

Authors:  Ines Tofe; Maria Dolores Ruiz-González; Maria Dolores Cañete; Asuncion Pino; Rosa Lorena Rueda; Maria Jose Parraga; Juan Luis Perez-Navero
Journal:  Front Pediatr       Date:  2018-02-14       Impact factor: 3.418

7.  Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.

Authors:  Carlo Dani; Chiara Poggi; Fabio Mosca; Federico Schena; Gianluca Lista; Luca Ramenghi; Costantino Romagnoli; Enrica Salvatori; Maria Teresa Rosignoli; Paola Lipone; Alessandro Comandini
Journal:  Trials       Date:  2016-04-02       Impact factor: 2.279

8.  Early PARacetamol (EPAR) trial: a study protocol for a randomised controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants.

Authors:  Tim Schindler; John Smyth; Srinivas Bolisetty; Joanna Michalowski; Kei Lui
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.